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The antigenic composition of cell surfaces is one of the present focal points of im- 
Inunogenetics, particularly as this may bear on the operation of selective gene action 
in specifying surfaces of cells following contrasting pathways of differentiation (1, 2). 
Far more is known about thylnocytes from this point of view than about any other 
cell type, because they are readily available as viable cells in free suspension and thus 
can easily be analyzed by serological methods, notably by the cytotoxicity test (3, 4). 
Although the cell surface antigens of skin are of great interest, this tissue has not 
been  studied  with  the  cytotoxicity method  because  of  the  diffi,  culty  in  obtaining 
satisfactory preparations of  viable single epidermal cells. The  one  exception is the 
recent study  of  Copper  and Lance  (5)  who  reported  the  demonstration  of  H-2  on 
enzyinatically dispersed cells, with the 51Cr-release cytotoxicity test (6,  7). From the 
standpoint of simplicity, visual reading with trypan blue (3,  4)  has advantages over 
the aCr-release version of the cytotoxicity test (6,  7) especially in studies that entail 
the testing of cells from many individual mice, when the extra steps involved in the 
51Cr-release  test become a  serious handicap; however, the trypan blue test demands 
cell suspensions of superior quality. We needed  to  apply the cytotoxicity test with 
epidermal cells  to  study  serologically a  new  system  of  alloantigens,  provisionally 
referred  to  as  Sk  t,  which  are  expressed on  epidermal cells but  not  on  heinopoiefic 
tissue, and so give rise to hoinograft responses directed selectively against skin (8, 9). 
In this report we shall describe the details of preparation that we have  found 
to be iinportant in obtaining epidermal cell suspensions of the standard required 
for  the  trypan  blue  test.  With  this  technique  we  have  been  able  to  make  a 
serological study of the surface antigenic composition of epidermal cells using  a 
variety of cytotoxic antisera belonging to known  systems  of alloantigens,  in- 
cluding Sk. 
* Supported in part by National Cancer  Institute grant CA 08748 and a grant from  the 
John A. Hartford Foundation, Inc. 
Recipient of fellowships from the Stiftung Volkswagenwerk and the Deutsche Forschungs- 
gemeinschaft. 
1 Abbreviations used in this paper: C, complement;  C3H,  C3H/An; B6,  C57BL/6;  FBS, 
fetal bovine serum;  MBLA,  mouse  specific bone  marrow-derived lymphocyte antigen(s); 
MSLA, mouse specific lymphocyte antigen(s) ; MSPCA, mouse specific plasma cell antigen(s) ; 
Sk, genetic locus (loci) specifying skin differentiation alloantigen(s). 
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Materials and Methods 
Mice.--These were obtained from our own colonies and included the following congenic 
stocks (C57BL/6 is abbreviated B6; C3H/An, C3H): on a strain A (0-C3H, TL  +) background, 
A/0-AKR and A/TL-; on an AKR (H-2 k) background, AKR/H-2b; on a B6 (H-2 b, Ly-A.2, 
Ly-B.2, TL-) background, B6/H-2 k, B6/Ly-A.1, B6/Ly-B.1, and B6/TL  +. 
Antisera.--See  Table I. 
TABLE  I 
Antisera 
Immunization  Abbreviated designation of  References  antiserum in text 
B6* anti-BALB/c ascites sarcoma Meth A 
DBA/2 anti-C57BL ascites leukemia EL4 
A anti-C57BL ascites leukemia EL4 
B6/TL+:~ anti-A strain spontaneous leukemia 
ASL1 
(A/0-AKRJ; X  AKR/H-2B:~)F1 anti-A strain 
spontaneous leukemia ASL1 
C3Hf/Bi anti-AKR thymocytes 
(B6 X  A)F1 anti-A/0-AKR:~ thymoeytes 
(BALB/c X  B6)Fi anti-B6/Ly-A.l~ 
thymocytes 
C3Hf/Bi anti-CE/J thymocytes 
B6/H-2k~ anti-CE/J thymocytes 
B6/Ly-B. 1 ~ anti-B6 leukemia ERLD 
(CBA/T6 X  SJL/J)Fi anti-C58 thymocytes 
C58 anti-CE/J thymocytes 
(A/TL-:~ X  B6)Fi anti-A strain spontaneous 
leukemia ASL1 
DBA/2 anti-BALB/c myeloma MOPC-70A 
B6  99  anti-B6 o  ~ skin (4 grafts) 
Lethally irradiated B6 mice restored with (B6 X 
A)Fi cells; serum taken after rejection of 3 
strain A skin grafts 
Lethally irradiated A mice restored with (B6 X 
A)Fi cells,  serum taken after 1 or 2 B6 strain 
skin grafts (see text) 
Anti-H-2  a 
Anti-H-2  b (i)§ 
Anti-H-2  b (ii) 
Anti-H-2  ~ 
Anti-0-C3H 
10 
Anti-0-AKR (i) §  11 
Anti-0-AKR (ii) 
Anti-Ly-A.1  10,  12 
Anfi-Ly-A.2  10,  12 
Anti-Ly-B.1  10,  12 
Anfi-Ly-B.2  10,  12 
Anti-Ly-C.1  12 
Anti-Ly-C.2  12 
Anti-TL.1,2,3 
Anti-PC.1  13 
Anti-H-Y  14 
Anti-Sk.1  8,  9 
Anti-Sk.2  8,  9 
* B6  =  C57BL/6. 
Congenic stock. 
§ These antisera are known to contain Ly antibodies also,  but the specificity named is 
the only relevant one in the experiments described in the text. 
Preparation of Epidermal Cells  for Cytoloxidty Tests.--Suspensions  of single epidermal cells 
were prepared by enzymatic dissociation  (15-17)  of  tail  skin.  Preliminary tests,  including 
comparison of trypsin, pronase, eollagenase, and hyaluronidase, led us to adopt the following 
procedure. A circular incision was made round the base of the washed tail, and a  second in- 
cision  along its  length. The  tail skin was peeled off in one piece and incubated at 37°C for 
3045 min in 1% trypsin (Bacto-Trypsin in Puck's saline). The time required for digestion of 
dermal-epidermal connections varied with the strain, sex,  and age of the donor.  After incu- 940  ALLOANTIGENS  O1  ~ MOUSE  EPIDERMAL  CELLS 
bation the  tail skin was  rinsed in Ringer's solution and spread out, dermal surface up, in a 
dry  Petri  dish.  With two  curved  forceps,  the loosened  dermis was  gently  separated  from 
the underlying epidermal sheet, and discarded. The exposed epithelial layer was then covered 
witha thin layerof medium 199 containing 10% fetal bovine serum (FBS: "IPT" =  immuno- 
precipitin-tested free of  7G; Grand Island Biological Co., Grand Island,  N.  Y.). With  the 
aid of a dissecting microscope, the surface was now lightly scraped with the tip of a fine-drawn, 
heat-polished Pasteur pipette; the overlying medium then was pipetted off and replaced with 
fresh medium from a  second pipette held in the other hand. This process was repeated several 
times. 
The loosened clumps of cells collected in this way were further dispersed by incubation in 
0.1%  trypsin for 10-20 min at 37°C.  The time required for dispersion varied, as it did  for 
the first trb~sinization. Two volumes of medium 199 containing 10% FBS were now  added 
and the cells washed three times by slow  centrifugation in the cold. Finally, any  remaining 
clumps of cells were removed by minimal slow centrifugation, single cells remaining in the 
supernate. The average yield was 5 X  106 cells/tail. The viable count, according to trypan blue 
exclusion, was 86-98%. 
A Comment on the Use of Trypsinized  Cells in Cytotoxicity  Tests.--Trypsin produces various 
functional and morphological effects on the cell surface  (18-22),  some of  them even at con- 
centrations as low as 5/zg/ml (19, 21). According to Poste (22), and certainly in our own ex- 
perience, repeated washing and addition of serum (probably to inactivate cell-bound trypsin), 
are important steps in preserving cell viability after trypsinization. Epidermal cells prepared 
as described in this report were examined by electron microscopy by our colleague Dr. Aoki. 
These showed the morphology typical of epidermal cells; the adverse signs reported by Ed- 
wards and Fogh (20) in other trypsinized cell types were not apparent. 
It is not possible to compare trypsinized with nontrypsinized epidermal cells in the cyto- 
toxicity test,  but it is possible to make the comparison with thymocytes and lymphocytes. 
We have done so, and have found that trypsinization, under conditions as similar as possible 
to those used for epidermal cells, did not alter the reaction of normal thymocytes and lympho- 
cytes to H-2, 0, Ly, and TL antisera in cytotoxicity tests. 
Cytotoxicity  Test.--The cytotoxicity test was based on the method of Gorer and O'Gorman 
(3) with modifications. The following conditions were found to be optimal for performing the 
test with trypsinized epidermal cells,  and particularly for obtaining satisfactorily low counts 
of dead cells in controls. 
Complement  (C):  Rabbits were individually selected for high C activity and low toxicity 
for thymocytes (about one rabbit in five is acceptable). The selected serum was absorbed with 
a  pool of various mouse cells,  including epidermal ceils,  to remove heteroantibody, the ab- 
sorption being carried  out in  the presence of  ethylenediaminetetraacetic acid  (EDTA)  to 
bind divalent cations and so prevent loss of C  during absorption.  (For a  full description of 
the method, which permits the use of relatively high concentrations of C without prohibitive 
toxicity, see reference 23.) 
Medium:  In a  preliminary survey, several media were tested for use in the preparation 
of epidermal cells and as diluents of antiserum and C  in the cytotoxicity test. Medium  199 
was chosen; the addition of 10% FBS was found to aid considerably in maintaining viability 
and did not noticeably diminish the sensitivity of the cytotoxicity test. 
Procedure:  Equal  volumes  (0.05  ml)  ot  (a)  antiserum,  serially  diluted,  (b)pooled  ab- 
sorbed rabbit serum (C source, diluted 1:8), and  (c) cells (5)<  106/ml) were incubated for 
45 min at 37°C. Cell counts, live and dead, were then made after addition of 0.1 ml freshly 
prepared 0.16% trypan blue. Controls were always included in which the test cells were in- 
cubated with  (a) antiserum alone, and  (b) C  alone. They contained less than 20% stained 
(dead) cells; these control data are not included in the tables. 
Typing ~( Cells or Tissues for the Presence or Absence qf Cell Surface Antigens by the Method 
of Absorptlon.--(For  details see reference 24.)  Antiserum of the required specificity was ti- M.  SCHEID,  E.  A.  BOYSE,  E.  A.  CARSWELL,  L.  J.  OLD  941 
trated (in doubling dilutions) against the relevant test cell, and a dilution two or three points 
below the end point selected. An aliquot of this diluted serum was mixed with an equal volume 
of washed, packed, viable ceils, or washed tissue homogenate, and incubated in test tubes of 
0.8 ml capacity for 30 mill on a shaker in the cold room. The absorbed serum was recovered 
by centrifugation in the cold and tested against the relevant cells for residual cytotoxic ac- 
tivity. Brain tissue was prepared for absorption tests by mincing with scissors, followed by 
gentle homogenization in a Teflon tissue homogenizer (Tri-R Instruments, Inc., Rockville 
Centre, N. Y.) in Earle's balanced salt solution. The homogenate was then washed three times. 
RESULTS 
I.  H-2  Antigen.--H-2  antisera  are  cytotoxic  for  epidermal  cells  (as  first 
shown by Cooper and  Lance [5]). The  specificity of  these reactions was con- 
TABLE II 
Demonstration oJ" H-2 Antigen on Epidermal Cells* 
Cell donor 
Cytotoxicity test on epidermal ceils  Hemagglutination 
test (reference  25)  H-2  b anti-H-2  a serum 
dilution  (% cells dead)  Results  H-2b anti-H-2a 
(+ or --)  serum results 
1/8  1/16  (+ or --) 
Controls 
Backcross mice 
A (H-2  ~)  66  72  +  + 
(B6)< A)F1  58  60  +  + 
B6 (H-2  b)  16  16  --  -- 
1  53  44  +  + 
2  20  17  --  -- 
3  50  48  +  + 
4  53  50  +  + 
5  15  17  --  - 
6  45  44  +  + 
* Specificity  is confirmed by these cytotoxicity tests on epidermal cells of (B6)< A)F1 
backcross mice independently typed for H-2 by hemagglutination. 
Other similar tests have invariably shown concordance between the two tests. 
X B6 
firmed (a)  by the use of H-2 antisera prepared in H-2-congenic stocks, (b) by 
positive tests with epidermal cells taken from congenic mice differing from the 
donors of the antiserum only at the H-2 locus, (c)  by negative tests with H-2 
antisera used in conjunction with epidermal cells of the  antiserum-producing 
strain,  and  (d)  by cytotoxicity tests  on epidermal cells from backcross  mice 
typed independently by hemagglutination (an example is given in Table II). 
H-2  cytotoxic titers were  considerably lower with  epidermal cells than with 
lymphocytes (see also reference 5). Reactions were also markedly weaker with 
heterozygote-positive than with  homozygote-positive, which  is  characteristic 
of relatively insensitive systems. 
II. 0 Antigen.-- 
(a)  Reaction  of  epidermal  cells  with  0  antisera  in  cytotoxicity  tests:  All  0 
antisera tested were cytotoxic for epidermal cells of mice carrying the pertinent 
0 allele, but not for epidermal cells of mice carrying the alternative allele. One 942  ALLOANTIGENS  OF  MOUSE  EPIDERM.A_L  CELLS 
of these 0  antisera was prepared in congenic mice differing only for 0  type. A 
confirmatory test is shown  in Table III. Eight A  strain mice  and seven A/0- 
AKR  congenic  mice  were  amalgamated  into  a  single  group;  epidermal  cells 
from each of them were then typed with 0 antisera while a second investigator 
typed their thymocytes in the usual way. A  comparison of the results showed 
complete concordance between the two tests. 
TABLE III 
Demonstration oj 0 Antigen on Epidermal Cells* 
Cell donor  Cytotoxiclty test  on epidermal cells  Typing of thymocytes 
Antisera  (dilution  1/8) 
Mouse  Anti-0-AKR  Result  amti_0_ C3 H  Anti-0-AKR  Strain  number  Anti-  (ii)* 
0-C3H  (i)~  (ii)+  + 
A(0-C3H)  1  80  20  12 
2  70  20  12 
3  68  19  12 
4  66  20  18 
5  70  22  18 
6  76  19  15 
7  76  13  13 
8  82  11 
A/0-AKR  1  14  72  60 
(congenic)  2  13  61  50 
3  18  70  50 
4  15  78  60 
5  13  78  65 
6  14  77 
7  19  80 
0-C3H  + 
+ 
+ 
+ 
+ 
0-AKR  -- 
+§  -II 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
* Specificity confirmed  by independent typing of epidermal calls and thymocytes of A 
strain (0-C3H) and congenic A/0-AKR mice; "blind" tests on a single amalgamated group 
of  15  mice. 
Different anfisera:  see  Table I. 
§ +  =  >  90%  cells dead. 
11 --  =  <  15%  cells dead. 
Specificity was  further  confirmed  by  absorption.  As  Table  IV  indicates, 
epidermal cells of 0-C3H type removed all activity of anti-0-C3H sera against 
0-C3H  thymocytes  and  epidermal  cells  and  this  absorption  is  serologically 
specific: 0-AKR epidermal cells did not absorb activity from the same serum. 
(b)  Production  of 0 antibody  by A  mice grafted with skin from congenic A/O- 
A KR mice:  As 0 antigen was seen to be present on epidermal ceils, it seemed 
likely that skin grafts between 0-incompatible mice would induce the formation 
of 0  antibody. This was  confirmed by grafting A  9  mice with  congenic A/0- 
AKR skin; Fig. 1 shows that the grafted mice formed 0 antibody, the specificity M.  SCHEID~  E.  A.  BOYSE,  E.  A.  CARSWELL,  L.  J.  OLD  943 
TABLE  IV 
Presence of 0 Antigen on Epidermal Cells Confirmed by Their  Capacity to  Absorb  0 Antibody 
Anti4-C3H serum (1/8) absorbed with* 
Cytotoxicity test with absorbed anti- 
serum (diluted 1/2) on A strain cells 
Thymocytes  Epidermal  cells 
(% dead)  (% dead) 
Result of 
absorption 
A strain (0-C3H) 
Thymocytes  20  19 
Epidermal cells  19  17 
A/0-AKR (0-AKR) 
Thymocytes  > 95  55 
Epidermal cells  >95  60 
Control: no absorption  >95  55-60 
+ 
+ 
* Method:  0.2  ml  anti-0-C3H  serum  (diluted  ~)  incubation  with  0.2  ml  of  packed, 
washed  cells for 30 rain at 40C. 
95 
N 
7O 
50 
7~30 
10 
A.  Not absorbed 
=2 
"--..,, AKR epd'l cells 
C3H epd'l cells  ~, 
• ,  A  *  *  _A  _A 
1/8  1/32  1/128 
B. Absorbed with 
C3H brain (O-C3H) 
--  ~._.%  AKR  \ 
",,~pdll cells\ 
\/ 
J_,  i  ,  I  , 
1/8  1/32  1/128 
Dilution of antiserum 
C. Absorbed with 
AKR brain(e-AKR) : 
AKR thy 
i  ,  i  ,  [  , 
1/8  1/32  1/i28 
FIG.  1.  Demonstration of 0 antibody in the serum of A  (0-C3H) mice grafted with skin 
from congenic A/0-AKR mice.  (A) The serum is cytotoxic for AKR strain epidermal cells 
and thymoeytes, but not for C3H  (0-C3H)  epidermal cells or  thymocytes.  (B) Absorption 
with AKR brain does not remove activity for thymocytes or epidermal cells,  whereas  (C) 
absorption  with  C3H  brain  removes  activity  for  both  thymocytes  and  epidermal  cells. 
* Method: 0.2 ml serum (diluted 1/8) incubated with 0.2 ml of packed washed brain homog- 
enate for 30 min at 4°C. 
of which was confirmed by positive  and negative  absorption  tests  with  AKR 
and C3H  brain, respectively,  as indicated in the figure. The  cytotoxic reaction 
against  lymph  node  lymphocytes  (not  shown  in  the figure)  was  considerably 
weaker  than  against  thymocytes,  which  is  characteristic  of  the  0  system.  0 944  ALLOANTIGENS OF  MOUSE EPIDERMAL CELLS 
antibody was found in the serum of several mice whose grafts showed no signs 
of rejection  (see Discussion). 
III. Sk A ntigen.--Although  the Sk system of antigens nlay eventually prove 
to comprise more than one Sk genetic locus, it will be referred to here  as if it 
were governed by alternative alleles at a single Sk locus, specifying Sk.1 antigen 
in the A  strain and Sk.2 antigen in B6. 
(a)  Serology of Sk.1  antigen:  Lethally  irradiated  B6  mice  restored  with 
(g6  X  A)F1 hemopoietic cells  reject  (B6  X  A)F~ and A  strain  skin  although 
they remain chimeric indefinitely  (8). The serum anti-Sk.1  was obtained from 
such chimeras that had rejected three A  strain skin grafts (see Table I). 
4O 
30 
m  :>, 
~.  20 
~ 
1  cell% 
A epd'l cells 
/(no antiserum: 
_  B6epd'lcells  /  NMS substituted) 
A/ controIi 
÷  ÷/~  ~..._..~  •  BM  "1 
!~-_-  "SPL  ~'A 
10 L  -_-_-_~:_-:-~  vLY  | 
a  THY  J 
Lm- .....  _~D  .....  -m- .....  -m- ..........  -m  vLY  l 
L  '  '  1  _  [  _ aTHYjj  B6 
1/8  lilb  1/32  1/gl  11128  11256  1/512 
Dilution of anti-Sk.1  serum 
Fro.  2.  Cytotoxicity  tests on epidermal cells, and other cells, with anti-Sk.1 serum [from 
(B6 X  A)Ft -~ B6 radiation  chimeras that rejected  (B6 X  A)F~ skin grafts]. The cytotoxic 
reaction is specific for A strain epidermal cells; B6 epidermal cells are not lysed, nor are bone 
marrow ceils, spleen ceils, lymph node lymphocytes,  or thymocytes of either B6 or A strain 
origin. NMS  =  normal mouse sermn. 
Anti-Sk.1  serum  was cytotoxic for A  strain  epidermal  cells but  not  for the 
B6  epidermal  cells,  nor  for  cells  of  thymus,  lymph  nodes,  spleen,  or  bone 
marrow from either strain of mouse  (Fig. 2). These serological findings accord 
with previous interpretations of skin homograft reactions directed to differentia- 
tion  alloantigens  present  on  skin  and  absent  from  hemopoietic  tissue  (Sk 
alloantigens). 
Absorption analysis of anti-Sk.1 serum confirmed the absence of Sk.1 antigen 
on thymocytes, lymph node lymphocytes, and spleen cells, and revealed that it 
is  present  on brain  (Table  V).  The specificity  of absorption  by brain  is  con- 
firmed in Table V  by the failure of Sk.1-  brain  (B6)  to absorb anti-Sk.1  anti- 
body. 
The presence of Sk.1  antigen on brain was further confirmed bv the finding M.  SCHEID,  E.  A.  BOYSE,  E.  A.  CARSWELL~  L.  J.  OLD  945 
that  the transplanted A  strain neuroblastoma C1300  is sensitive to anti-Sk.1 
serum (but not to anti-Sk.2 serum [see below]), to about the same degree as A 
strain  epidermal  cells  (Fig.  3).  A  number  of  other  tumors  were  tested  with 
anti-Sk.1  serum, but none was found sensitive (Table VI). 
TABLE  V 
Representation of Sk.1  Antigen on Cells  of Various Tissues Determined by  Their Capacity to 
Absorb Sk.1 Antibody 
Anti-Sk.1 serum (1/8) absorbed with* 
Cytotoxicity test with 
absorbed antiserum 
1/15  t/25 
(%Aepidermal cells dead) 
Result of absorption 
A strain (Sk.1  +) 
Epidermal cells  15  15  + 
Brain  14  14  + 
Thymocytes  40  42  -- 
Lymph node lymphocytes  42  43  -- 
Spleen cells  39  42  -- 
B6 (Sk.1-)  (controls) 
Epidermal cells  40  42  -- § 
Brain  40  49  -- § 
* For method see footnote to Table  IV. 
$ Residual  cytotoxic  activity  of  absorbed  antiserum  against  A  strain  epidermal  cells 
without further dilution  (~)  or  diluted  (~). 
§ These negative results show that absorption of anti-Sk.1 antibody by A strain epidermal 
cells and blain (above) was serologically specific. 
FIG.  3. 
70 t  ~""---~Afitrain  epidermal cells 
50  "~. --,i.-- .......  jk .(,.Neu  roblastoma C1300 
in) 
~'10 l  i-  .....  -B-  ....  ..n-~  -'m----  __  B6 epidermal ceils  \  \'~' 
t  L~_.  ~  L__  I 
1/8  1/16  1/32  1/64  1/128--  1/256 
Dilution of anti-Sk.1 serum 
Sk.1 antigen is present on neuroblastoma C 1300  cells of the A strain. 
(b) Serology of Sk.2 antigen:  Similar chimeras in which the other component 
of  the  cross  is  used  as  the  recipient,  i.e.  irradiated  A  mice  restored 
with  (B6  X  A)F1  hemopoietic  cells,  formed  the  antibody  anti-Sk.2  when 
grafted with B6 skin. Not all such grafts are rejected (8), but we find that those 
chimeras that retain their B6 grafts without  evidence of rejection frequently 
have  good  titers  of  anti-Sk.2  antibody,  not  significantly  lower  than  those 946  ALLOANTIGENS  OF  MOUSE  EPIDERMAL  CELLS 
chimeras  that  rejected their  grafts.  This  retention  of skin grafts  despite  the 
formation of antibody to epidermal cell antigens is similar to what was observed 
in the 0 system (see section II above). 
(c) Linkage:  The only loci for which close linkage has so far been excluded 
are H-2  and  Tla,  indicated by  typing epidermal cells of congenic  mice  with 
anti-Sk.1 and anti-Sk.2 sera (Table VII). 
TABLE VI 
Cytotoxicily Test for Sk.1 Antigen on Various Tumors 
Tumor* 
Spindle-cell sarcoma Sal (a) 
Epithelioma DMBA 788  (b) 
Epithelioma DMBA 592  (b) 
Anaplastic carcinoma 
15091A (a) 
Adenocarcinoma 
TA3/Ha41 (e) 
Spontaneous  mammary 
carcinoma (d) 
Neuroblastoma C1300 (a) 
% cells 
3,louse strain  Ascites or subcu-  lysed by  Result 
of oligin  taneous transplant  anti-Sk.1. 
serum (1/8) 
A  Ascites  5  -- 
XVII  Subcutaneous:~  10  -- § 
XVII  Subcutaneous:~  10  -- § 
A  Subcutaneous:~  10  - 
A/HeHa  Ascites  5  -- 
A/0-AKR  Subcutaneous~  15  -- 
A  Subcutaneous~  60  + 
* Tumors obtained from:  (a)  N. Kaliss, The Jackson Laboratory, Bar Harbor, Maine; 
(b) G. Pasternak, Deutsche Akademie der Wissenschaften, Institut fiir Medizin und Biologic, 
Berlin-Buch;  (c) T. S. Hauschka, Roswell Park Memorial Institute, Buffalo, N.Y.; and (d) 
our  own  stock. 
:~ Cells prepared for cytotoxicity test by trypsinization. 
§ As the Sk genotype of strain XVII is not known, the negative results do not necessarily 
signify that  these  epitheliomas  lack Sk alloantigens. 
TABLE VII 
Close Linkage  of Sk  with  11-2 or  Tla  is  Excluded 
Typing of epidermal cells  Strains 
Sk.1-/Sk.2  +  B6. B6/TL  +, B 10.A (C57BL background) 
Sk.l+/Sk.2  -  A, A/TL-, A.BY (A background) 
also AKR, C3H, CBA(Lyon! 
IV. H-Y  (Male)  Antigen.--Anti-H-Y  serum was  obtained  from  B6 females 
that had rejected three or more B6 male skin grafts. This antiserum is cytotoxic 
for sperm,  and  the reaction is specific for  H-Y antigen (14).  Anti-H-Y  serum 
is not  cytotoxic for cells from thymus,  spleen, lymph  nodes,  or bone  marrow, 
although  these  tissues  absorb  anti-H-Y  activity;  evidently  H-Y  antigen  is 
present  in amounts too small  to give a  positive test, or it is present on only a 
small proportion of such cells (14); the former seems more probable. 
Anti-H-Y  serum  was  strongly  cytotoxic  for  male  epidermal  cells  (Fig.  4, M.  SCHEID,  E.  A.  ]30YSE,  E.  A.  CARSWELL,  L.  J.  OLD  947 
Table VIII). Specificity was confirmed by showing that male epidermal cells, 
but  not  female  epidermal  cells,  removed  all  cytotoxic activity against  male 
epidermal cells  (Table VIII). 
As noted previously with sperm (14) there were substantial differences among 
mouse  strains  in  the  sensitivity of  male  epidermal  cells  to  anti-H-Y  serum 
(Fig.  4).  Further  work  is  needed  to  establish  whether  these  differences are 
due to (a) strain differences in susceptibility to complement-mediated cytolysis 
(as we have observed in another system),  (b) strain differences in the amount 
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FIG. 4.  Cytotoxic effect of anti-H-Y serum (from B6 female rejectors of B6 male skin) 
on male epidermal cells of various strains. Anti-H-Y serum was positive against male epi- 
dermal cells of all strains tested with marked differences in sensitivity from strain to strain, 
but not against female epidermal cells. On the right are shown the percentages of sperm lysed 
by anti-H-Y serum, the sperm donors being selected from the strains whose epidermal cells 
were tested (left). It is seen that the sensitivity of sperm tends to parallel the sensitivity of 
epidermal cells for each strain. 
of  H-Y  antigen  present  on  the  cell  surface,  or  (c)  strain  differences in  the 
antigenic specificities of H-Y antigen (see reference 26). 
V. TL, Ly-A, Ly-B,C, and PC Alloantigens.--The  antisera which  belong to 
these systems and which we have tested against  epidermal cells  are listed in 
Table I; none gave a  positive cytotoxicity test.  One antiserum,  anti-Ly-B.1, 
was also tested by absorption with epidermal cells of Ly-B.1 mice, which failed 
to remove cytotoxic activity against Ly-B.1 thymocytes. We conclude that Ly 
antigens are lacking on epidermal cells. Similarly anti-PC.1 and  anti-TL.1, 2, 3 
sera were not cytotoxic for epidermal cells, nor did epidermal  cells  from PC.1 
or TL.1, 2,  3  mice remove anti-PC.1  or TL.1, 2,  3  activity in  the  standard 
absorption test for PC.1 or TL.1, 2, 3. 948  ALLOANTIGENS OF  MOUSE  EPIDERMAL  CELLS 
DISCUSSION 
Genetic Specification  of Cell Surface Composition of Di~erentiated Cells.--The 
serological investigation  of cell surfaces has usually centered on antigenic dif- 
ferences among individuals  of a  species,  a thorough comprehension of which is 
the essence of transplantation biology. The serological techniques used for that 
purpose can be applied equally to studying surface antigenic differences among 
various  cell  populations  in  a  single  individual.  A  priori,  such phenotypic dif- 
ferences are likely to have wider biological relevance than the genotypic varia- 
tion  responsible  for histoincompatibility,  because  they  imply  that  there  are 
patterns of selective gene action which govern the composition of different cell 
surfaces  in  accord with  the  requirements  of  particular  pathways  of  differen- 
tiation;  and this may  well  be  critical  to  the  problem  of  relating  genetics  to 
TABLE VIII 
Specificity q( the Anti-H-Y Cytotoxlc Reaction on Male Epidermal Cells Confirmed by 
Absorption Tests with Male or Female Epidermal Cells 
Cytotoxicity test with 
absorbed  antiserum 
Anti-H Y serum (1/8) absorbed  with*  Result of absorption 
1/t~  1/2~ 
(% B6cP epidermal cells dead) 
B6 9  epidermal cells  57  60  - 
B6cP epidermal cells  15  16  + 
Control: no absorption  55  57 
* For method see footnote  to Table IV. 
++ Residual  cytotoxicity of  absorbed  serum  tested  against  B6  epidermal  cells without 
further dilution  (}~) or diluted  (~). 
morphogenesis and to other  manifestations of cellular interaction,  as  discussed 
more fully elsewhere  (2). 
The data summarized in Table IX, which  is an inventory of surface antigens 
classified according to the types of cell on which they appear, can be viewed as 
a fragment of the mouse's genetic program of cell  surface specification, for the 
presence of a certain set of components on one cell,  and  a different set on an- 
other, is attributable to selective gene action, regardless of whether the presence 
or absence  of antigen  at  accessible  sites  is directly due  to expression  vs. non- 
expression of structural genes coding for these antigens, or to a less direct genetic 
mechanism. 
The total surface of a cell could in theory be described in terms of an assembly 
of components specified by a certain set of genes (2). What proportion of these 
genes are expressed only conditionally, i.e.,  only in consequence of a particular 
mode of differentiation? A  hint of the answer comes from the fact that of the 
many systems of antigens  demonstrable  serologically on nucleated cells of the 
mouse,  only H-2 is  expressed  on  apparently  all  cells  (1),  suggesting  that  the M.  SCHEID,  E.  A.  BOYSE,  E.  A.  CARSWELL,  L.  J.  OLD  949 
proportion of conditionally  expressed loci may indeed  be high.  So it  may be 
that differentiation is the source of more radical differences in cell surface com- 
position than is intraspecies genetic variation,  or even than the  wider  genetic 
divergences separating species, genera, etc. This is somewhat contrary to past 
impressions and the case for it is argued from other aspects and in more detail 
elsewhere (2). 
Other Considerations.--The  antigenic phenotype of epidermal cells revealed 
by this study has several implications, especially for transplantation  biology: 
(a) It is important that the Sk alloantigens are now identified serologically 
as  differentiation  alloantigens  confined to epidermal cells  and brain,  because 
their demonstration has previously depended wholly on the results of grafting 
in vivo (8, 9). Recognition of the Sk system removes much of the mystery from 
what formerly seemed to be anomalous cases of skin rejection by hemopoietic 
TABLE IX 
Selective Gene Action  Exemplified for Se'jeral Loci Coding for Cell Surface Components 
H-2  H-Y  Sk  0  Pca  Ly-A  Ly-B,C  Tla 
Epidermal cells  +  +  +  +  .... 
Sperm  +  +  ...... 
Brain  +  +  +  +  +  --  --  -- 
Plasma  cells  +  --  --  +  --  --  -- 
Lymphocytes  +  +  --  +  -  +  +  -- 
Thymocytes  +  +  --  +  --  +  +  + 
Erythrocytes  +  ...... 
+  =  expressed. 
--  =  not expressed. 
chimeras,  and  from at  least some instances  of  "split  tolerance."  To take  an 
example of the latter, the rejection of C57 skin grafts by [(CBA X  C57) ~  A] 
chimeras, in the face of acceptance of CBA skin grafts (27, 28), is readily under- 
stood on the basis of our Sk typing of epidermal cells from the three strains 
concerned, for A  and CBA epidermal cells type as Sk.1,  and  C57  (B6)  types 
as Sk.2 (Table VII). 
Presumably the observed qualitative differences in antigen phenotype among 
contrasting  cell  populations  in  the  same  individual,  arising  evidently  from 
selective gene action geared to cellular differentiation, contribute to observed 
differences in the fate of grafts of different organs or tissues from donors of the 
same genotype (29-35),  and to the different tolerance-inducing capabilities of 
contrasting cell populations (cf. especially references 34-39).  The relevance of 
this to tissue typing for purposes of human organ transplantation is self-evident. 
(b) There has been considerable discussion of the possible role of "passenger" 
leukocytes in immunizing the recipients of tissue grafts, and so facilitating re- 
jection  (40-42).  The  fact  that  rejection  of  Sk-incompatible  skin  grafts  by 950  ALLOANTIGENS  OF  MOUSE  EPIDERMAL  CELLS 
chimeras may occur rapidly and  is  attributable  solely to Sk incompatibility, 
meaning by definition incompatibility due to antigens not carried by leukocytes, 
indicates that the presence of leukocvtes sharing pertinent antigens with epider- 
mal cells is not essential to a rapid and fully effective skin homograft response 
(whatever the part played by passenger leukocvtes may be under other condi- 
tions of grafting). And, conversely, isolated 0 incompatibility is often or even 
usually insufficient to cause rejection of skin grafts despite the fact that 0 is 
carried by passenger lymphocytes, as well as by epidermal cells. 
(c) A point of possible clinical relevance concerns the reputed immunological 
basis  of such  skin disorders as pemphigus and bullous pemphigoid, in which 
serological evidence of anti-skin immune responses has been obtained (43-45). 
Realization that the surface antigen phenotype of epidermal cells is character- 
istically distinguished from that of imnmnocompetent cells of the same individ- 
ual  mouse suggests  that  the source of autoantigens  involved in such human 
diseases may be the general class of cell surface antigens that are expressed on 
epidermal cells but not on immunocompetent cells.  Experience with lymphoid 
cell differentiation antigens (1) indicates that the class of "skin differentiation 
antigens" will  prove to include antigens shared by all members of the species 
(comparable  with  mouse  specific lymphocyte antigen[s]  [MSLA,  46],  mouse 
specific bone  marrow-derived lymphocyte antigen[s]  [_X{BLA, 47],  and mouse 
specific  plamsa  cell  antigen[s]  [~ISPCA,  48]  on  lymphoid  cells)  as  well  as 
skin  differentiation  alloantigens  of  the  type  represented  by  Sk  (although 
this has not so far been investigated with the necessary heteroantisera).  The 
former are  perhaps  more  likely  candidates  as  autoantigens.  (See  references 
49  52  for  relevant  studies  with  immunofluorescence.)  In  general  perhaps 
the  spectrum  of  tissues  affected  in  different  autoimmune  diseases  reflects 
the differential expression ("tissue representation")  of the particular cell  sur- 
face  differentiation  antigen(s)  involved in each case. This is  not to say any- 
thing  very new  about  autoimmunity,  and is intended only to stress  (a)  the 
importance of antigens at the cell surface as the target of imnmnological attack 
leading to tissue injury, and (b)  that  differential surface  antigenicity has now 
been proved for nonlymphoid cells  (epidermal cells)  which  do not  occupy a 
"privileged" (53, 54) site. 
(d)  The serological demonstration  of Sk  alloantigens is invaluable for pur- 
poses of future genetic analysis, and in proving the existence of skin-selective 
homograft rejections,  a  possibility that had been entertained for some years 
(see e.g. references 31, 34, 35, 55) but has only recently been substantiated by 
critical experiments (8,  9). There will  doubtless be discussion of the biological 
role of Sk antibodies, as indeed there continues to be discussion of the role of 
humoral  antibodies,  as opposed to cell-mediated immunity, in graft rejection 
generally. Certainly the presence of Sk antibodies (and as we find in preliminary 
grafting experiments in the 0 system, the presence of 0  antibodies)  does not 
signify that rejection has taken place or will take place. We commonly find that M.  SCHELD,  E.  A.  BOYSE,  E.  A.  CARSWELL,  L.  J.  OLD  951 
some  [(B6 X  A) --+ A] chimeras retain B6 skin grafts apparently indefinitely 
despite the formation of anti-Sk.2 antibody, and that the same is often true of 
accepted 0-incompatible skin grafts (see Results IIb). This suggests comparison 
with the description given by Hellstr6m of other situations where incompatible 
tissue  is  retained  despite  antibody production  (56-60).  As  Hellstr6m  et  al. 
(56-60) and Voisin et al.  (61)  point out, tolerance does not necessarily involve 
total abrogation of the immune response, and in some instances immunological 
enhancement may  be  the  most  appropriate  mode  (162, 63),  but  clearly the 
situation with tolerated hemopoietic allografts (hemopoietic chimerism) is not 
to  be  equated  with  situations  in  which  Sk-incompatible  skin  allografts  are 
tolerated, as described in this report. In other words, although on the one hand 
the Sk cytotoxic antibody response of those radiation chimeras that happen to 
retain Sk-incompatible skin grafts may be no different from that of apparently 
identical radiation chimeras that happen to reject them, on the other hand ac- 
ceptance of hemopoietic grafts, necessary for the establishment of those radia- 
tion chimeras, is never (as far as we can tell)  accomplished in the face  of an 
anti-H-2 or any other antibody response against hemopoietic cells that is recog- 
nizable by conventional cytotoxicity or hemagglutination tests. 
(e) Of all the antigen systems now identified on epidermal cell surfaces, the 
one that most demands further definition is Sk,  because of its  relevance to so 
many facets of cell surface specification and  of transplantation  biology.  To 
begin with, Sk.1 and Sk.2 may in fact represent more than one genetic system, 
and the particular vigor of A strain graft rejection by [(B6 X A) ~  B6] chimeras 
may reflect a summation of multiple Sk incompatibilities rather than one major 
Sk incompatibility; (we recall that the first Ly antisera to be analyzed turned 
out to identify two genetically separate Ly systems [10]).  Genetic tests will be 
necessary to decide this. Identification of a linkage group or groups is important 
in this respect; all we know so far is that there is no close linkage of Sk with 
H-2: Tla. A major question is, "Why are Sk incompatibilities usually not associ- 
ated with such vigorous rejection as that seen in  [(B6 X  A)  -+ B6] radiation 
chimeras?" There are several well-known possibilities that have been thoroughly 
aired in connection with other systems in which graft rejection is inconsistent, 
but one is perhaps of special interest, and that is the explanation raised by the 
finding that mice with accepted Sk-incompatibile or 0-incompatible skin grafts 
may nonetheless be producing Sk or 0 antibody. This cannot fail to suggest that 
the answer may lie in the quality of the immune response, as reflected in the 
balance  between  the  cell-mediated  immune  response  and  the  production  of 
humoral antibody, which in weak systems particularly may decide whether the 
outcome will be acceptance or rejection. 
SUMMARY 
Single cells were prepared from mouse tail epidermis by a method which gives 
high viability counts and so permits their use in cytotoxicity tests. 952  ALLOANTIGENS OF  MOUSE  EPIDERMAL  CELLS 
According  to  tests  with  standard  alloantisera,  the  antigen  phenotype  of 
mouse epidermal cells is H-2+0+Sk+H-Y+TL- Ly-A- Ly-B,C- PC-. 
The  skin  differentiation alloantigen Sk,  which  is responsible for  homograft 
reactions directed selectively against skin, is expressed also on brain, but not on 
other cell types; it is present on the transplanted neuroblastoma C1300.  Cyto- 
toxicity tests with  epidermal cells of H-2  congenic mouse stocks confirm that 
the Sk locus is not closely linked to H-2. 
The lymphoid cell differentiation antigen 0 also is present on both epidermal 
cells and brain. Mice frequently retain 0-incompatible or Sk-incompatible skin 
grafts although they have formed substantial titers of 0 or Sk antibody  in re- 
sponse to grafting. 
Male (H-Y)  antigen is demonstrable on epidermal cells by cytotoxicity tests 
with H-Y antibody, as it is also on one other type of cell, spermatozoa. 
We are indebted to Miss Chika Iritani for the H-2 hemagglutination tests, to Mrs. Ellen 
Goldberg for the cytotoxicity tests on sperm, and to Miss Mary John for assistance in pre- 
paring antisera and complement. 
Note Added  i~ Proof.--Hildemann and Pinkerton, using a hemolytic plaque assay, 
report the presence of H-Y antigen on erythrocytes of male mice (Hildemann, W. H., 
and W. Pinkerton.  1966. Alloantibody production measured by plaque assay in rela- 
tion to strong and weak histoincompatibility. J. Exp. Med. 19.4:885). 
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